In a new study published in Trends in Biotechnology, researchers used a gene-editing technology called CRISPR to increase a ...
WASHINGTON, D.C.– The U.S. National Security Commission on Emerging Biotechnology issued its first report since its creation through the National Defense Authorization Act of FY2022. The bipartisan ...
Although existing CRISPR-Cas-based imaging methods can target endogenous genomic sequences, their applications are limited by system complexity and sensitivity, particularly when imaging ...
The Biomanufacturing Excellence Act creates a national Center of Excellence to drive innovation in biopharmaceutical ...
The Manila Times on MSN
Biotechnology key to unlocking healthier, more sustainable future
THE Philippines is on the cusp of a biotechnological revolution, with the potential to transform the country's agriculture, food security, and public health. A recent forum in Manila brought together ...
The Southeast Asian Regional Center for Graduate Study and Research in Agriculture (Searca) participated in the recent ...
The National Security Commission on Emerging Biotechnology (NSCEB) delivered its major report and action plan to Congress in early April with a blunt message: the world is entering a new age driven by ...
Browse investing articles and stock analysis by George Budwell, PhD. Get expert financial insights and investment advice from The Motley Fool.
Using biological agents as weapons is illegal, but an organism that scientists lawfully use for genuine research could be repurposed for an attack. Therefore, what is banned depends on what an actor ...
GATE Biotechnology Syllabus 2026: Aspiring participants of the GATE 2026 Biotechnology (BT) exam must go through the GATE Biotechnology Syllabus. The detailed syllabus for GATE 2026 Biotechnology has ...
DUBLIN--(BUSINESS WIRE)--The "Royalty Rates in Pharmaceutical and Biotechnology Deals" report has been added to ResearchAndMarkets.com's offering. Royalty Rates in Pharmaceutical and Biotechnology ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results